Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Non-interventional, Multi-centre Study to Investigate the Change in Clinical and Patient-reported Outcomes in Moderate to Severe COPD Patients Treated With TRIXEO (Budesonide / Glycopyrronium / Formoterol) Under Real-life Conditions

NCT05213611 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT05213611
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05213611 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Non-interventional, Multi-centre Study to Investigate the Change in Clinical and Patient-reported Outcomes in Moderate to Severe COPD Patients Treated With TRIXEO (Budesonide / Glycopyrronium / Formoterol) Under Real-life Conditions
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
August 11, 2022
Completion date
July 8, 2024
Enrollment
150 (actual)
Sites
31

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease